Novel Nonsecosteroidal Vitamin D Receptor Modulator Combined with Gemcitabine Enhances Pancreatic Cancer Therapy through Remodeling of the Tumor Microenvironment

Zisheng Kang,Cong Wang,Yu Tong,Yanyi Li,Yi Gao,Siyuan Hou,Meixi Hao,Xiaolin Han,Bin Wang,Qianqian Wang,Can Zhang

DOI: https://doi.org/10.1021/acs.jmedchem.0c01197

IF: 8.039

2020-12-31

Journal of Medicinal Chemistry

Abstract:In a pancreatic tumor microenvironment, activated pancreatic stellate cells (PSCs) produce extracellular matrix (ECM) to form a barrier to drug penetration. Moreover, the interaction between cancer cells and activated PSCs promotes the tumor growth. Vitamin D receptor (VDR), as a key regulator to promote the recovery of PSCs to the resting state, is an attractive therapeutic target for pancreatic cancer. Herein, we reported the design and synthesis of 57 nonsecosteroidal VDR modulators based on the skeleton of phenyl-pyrrolyl pentane. Among them, compounds <b>C4</b>, <b>I5</b>, and <b>I8</b> exhibited excellent VDR affinity and effective inhibition of the activation of PSCs, as well as potent suppression of the interaction between cancer cells and PSCs <i>in vitro</i>. <i>In vivo</i>, compound <b>I5</b> combined with gemcitabine achieved efficacious antitumor activity without causing hypercalcemia. In conclusion, the compounds designed in our study can remodel the tumor microenvironment and are expected to be candidates for the treatment of pancreatic cancer.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01197?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01197</a>.(Table S1) Cell toxicity of all target compounds against LTC-14; (Figure S1) cell toxicity of representative compounds against DSL-6A/C1 cells; (Figure S2) relative BLI intensities of mice that received different treatments; (Figure S3) inhibition rate of tumor growth after tumor-bearing mice received different treatments; (Figure S4) relative fluorescence intensities of α-SMA after mice received different treatments; (Figure S5) survival percentages of mice that received different treatments; (Figure S6) <i>in vivo</i> hypercalcemic effects in the orthotopic transplantation pancreatic cancer model; NMR spectra information; HPLC traces; and ¹H NMR and ¹³C NMR spectra (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01197/suppl_file/jm0c01197_si_001.pdf">PDF</a>)Molecular Formula Strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01197/suppl_file/jm0c01197_si_002.csv">CSV</a>)This article has not yet been cited by other publications.

chemistry, medicinal